Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Taofeek K. Owonikoko | Researchclopedia

Back to researchers

Taofeek K. Owonikoko

University of Maryland, Baltimore ORCID

735

Works

64,653

Citations

88

h-index

260

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Genomics and Diagnostics

Affiliations

Rutgers, The State University of New Jersey2013–2013

Università Cattolica del Sacro Cuore2018–2018

Hebron University2023–2023

University of Maryland, Baltimore2024–2026

National Institutes of Health2014–2015

Top Works

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden,Danny Rischin,et al.

20181,363 citations

Cancer Immunotherapy and Biomarkers

Cancer therapeutics and mechanisms

Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

Alice O. Kamphorst,Andreas Wieland,et al.

2017990 citations

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients

Alice O. Kamphorst,Rathi N. Pillai,et al.

2017857 citations

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth,Eric J. Sherman,et al.

2020743 citations

Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database

Taofeek K. Owonikoko,Camille Ragin,et al.

2007568 citations

Lung cancer: New biological insights and recent therapeutic advances

Suresh S. Ramalingam,Taofeek K. Owonikoko,et al.

2011483 citations

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Myung‐Ju Ahn,Byoung Chul Cho,et al.

2023423 citations

Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth

Taro Hitosugi,Lu Zhou,et al.

2012422 citations

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

M. Catherine Pietanza,Saiama N. Waqar,et al.

2018393 citations